IFITM3 and gastric cancer: Although IFITM3 had been reported to engage in different regulatory signaling pathways to exert oncogenic functions in several other cancer types, IFITM3 was only suggested to be a potential target of the Wnt/β-catenin signaling in gastric cancer [50].